RetractedArticleDisease markers2023

Retracted: Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma.

Disease MarkersPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.